Zebra Medical, Telerad Tech Partner for Health Care Technology

Medical imaging developer Zebra Medical Vision Ltd. and teleradiology technology company Telerad Tech Pvt. Ltd. have signed a partnership to bring Zebra Medical’s cloud-based deep learning analytics engine to more than 20 countries and 150 hospitals and health care organizations.

Zebra Medical Vision partners with Telerad Tech, the technology arm of India’s first and largest teleradiology company, Teleradiology Solutions (TRS) Corp. Courtesy of Zebra Medical Vision.

"Our company is proud to serve health care systems that treat millions of patients in over 20 countries globally," said Dr. Arjun Kalyanpur, founder and CEO of Teleradiology Solutions and Telerad Tech. “Our emphasis and focus has always been on high-quality radiology reporting and accessibility. Zebra's ability to produce and deploy artificial intelligence for radiology is the exact type of added value we hope to bring to help fulfill our vision of impacting patient diagnosis and medical care in India, Asia and Africa."

The agreement is scheduled to be signed as part of the visit of India’s Prime Minister to Israel, further strengthening the growing commercial and technological ties between the two countries.

“Zebra’s mission has always been to make radiology more accessible and affordable globally,” said Elad Benjamin, co-founder and CEO of Zebra Medical Vision. “Our partnership with Telerad Tech will help us bridge the growing gap between demand and supply of radiology services, and allow developing health care economies to make a leap in their quality of care by using state-of-the-art deep learning technology.”

Zebra Medical Vision’s platforms allow health care institutions to identify patients at risk of disease and offer improved, preventative treatment pathways to improve patient care. Teleradiology Solutions provides teleradiology services such as computed tomography, medical resonance imaging, X-ray, ultrasound, nuclear medicine and echocardiograms to hospitals around the globe.